Chilean exploration concessions granted for Speciality Metals

Published 14-MAR-2018 11:56 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Speciality Metals International Limited (ASX:SEI) has informed the market that it has been granted an additional 15 Exploration Concessions by Chilean courts.

The company is now in the process of transferring the concessions, which are located over a key region of Salar de Pintados (Pinta 1-15), into its wholly owned Chilean based subsidiary Special Metals Chile SpA.

Pinta 1-15 cover a significant portion of western Salar de Pintados near where Albermarle corp and SQM S.A. produce a third of the world’s lithium from lithium brines.

The concessions are also in close proximity to the Pan American Highway and lithium processing infrastructure at the port of Antofagasta.

These additional concessions complement the existing five Exploration Concessions granted in Salar de Bellavisa and the further five Exploration Concessions granted in 2017 in Salar de Miraje (below).

Speciality metals chile exploration

SEI Executive Chairman Russell Krause commented on the development, “The granting of the final parcel of Exploration Concessions will enable the Board and its geological team to implement its lithium diversification strategy via a targeted drilling program to commence once the assays from the last round of surface samples have been received and analysed.

“The company’s upcoming drilling program has been designed to sample the ground waters at depth within each salar, to confirm the presence of lithium-bearing ground waters occurring within the subsurface where previous surface sampling found conspicuously anomalous lithium, boron and potassium values in surface crusts and brines accumulated in surface depressions.”

It should be noted that SEI is an early stage company and investors should seek professional financial advice if considering this stock for their portfolio.

About Speciality Metals International Limited

Speciality Metals International Limited (ASX:SEI), formerly Carbine Tungsten Limited (ASX:CNQ), plans to become a leading Australian tungsten producer via its historic Mt Carbine tungsten mine in north Queensland.

The company has expanded its exploration portfolio to include the following diversified projects:

  • Lithium and other resources including potassium, iodine and boron contained within subsurface brines within its Chilean exploration concessions
  • Gold exploration licenses (Panama Hat and Crow Mountain) in NSW, Australia

SEI will continue to evaluate corporate and exploration opportunities within the speciality metals sector.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X